Funder: National Institutes of Health
Due Dates: May 25, 2025 (New, Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | September 25, 2025 (New, Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | January 25, 2026 (New, Renewal/Resubmission/Revision)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period is 5 years.
Summary: Supports large-scale, high-impact clinical trials and complex studies evaluating interventions for vision disorders, including gene and stem cell therapies.
Key Information: Clinical trial required; only complex/high-risk studies are eligible; full clinical protocol and milestone plan required at submission.